Stockscreener 앱 받기
0.8692
25.07%
-0.2908
시간 외 거래:
.92
0.0508
+5.84%
전일 마감가:
$1.16
열려 있는:
$1.15
하루 거래량:
4.11M
Relative Volume:
3.04
시가총액:
$51.10M
수익:
-
순이익/손실:
$-123.46M
주가수익비율:
-0.3356
EPS:
-2.59
순현금흐름:
$-104.11M
1주 성능:
+10.03%
1개월 성능:
+25.97%
6개월 성능:
+127.42%
1년 성능:
-37.47%
1일 변동 폭
$0.84
$1.19
1주일 범위
$0.82
$1.43
52주 변동 폭
$0.2601
$1.90
바이오아틀라 Stock (BCAB) Company Profile
명칭
Bioatla Inc
전화
858-558-0708
주소
11085 TORREYANA ROAD, SAN DIEGO
BCAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.8692 | 68.20M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
바이오아틀라 Stock (BCAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-13 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-11-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | 개시 | JMP Securities | Mkt Outperform |
| 2022-05-05 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | 개시 | H.C. Wainwright | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-06-28 | 개시 | ROTH Capital | Buy |
| 2021-05-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-01-11 | 개시 | BTIG Research | Buy |
| 2021-01-11 | 개시 | Credit Suisse | Outperform |
| 2021-01-11 | 개시 | JP Morgan | Overweight |
| 2021-01-11 | 개시 | Jefferies | Buy |
모두보기
바이오아틀라 주식(BCAB)의 최신 뉴스
Form 424B5 BioAtla, Inc. - StreetInsider
BioAtla Secures $7.5 Million Pre-Paid Advance - TipRanks
BioAtla’s New Funding: A Double-Edged Sword for Shareholders - Ad-hoc-news.de
BioAtla Agrees to $22.5 Million in Financing Agreements - MarketScreener
BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing - Investing News Network
BioAtla, Inc. Secures $7.5 Million Financing to Support Operations During Strategic Partnership Negotiations - Quiver Quantitative
BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing - GlobeNewswire Inc.
Is BioAtla Inc (BCAB) Good For Your Portfolio? - fostersleader.com
Regression analysis insights on BioAtla Inc. performanceWeekly Trend Summary & AI Enhanced Market Trend Forecasts - newser.com
What catalysts could drive BioAtla Inc. stock higherProfit Target & Fast Gain Swing Trade Alerts - newser.com
Measuring BioAtla Inc.’s beta against major indicesTrade Analysis Report & Community Consensus Trade Alerts - newser.com
BioAtla Inc. stock outlook for YEAR2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - newser.com
Bioatla Shares Surge on Strong Clinical and Financial Results - Ad-hoc-news.de
Sentiment analysis tools applied to BioAtla Inc.Take Profit & Verified Momentum Watchlists - newser.com
What moving averages say about BioAtla Inc.Portfolio Return Summary & Accurate Entry/Exit Alerts - newser.com
BioAtla Inc (BCAB) can make a big difference with a little luck - Setenews
Analyzing BioAtla Inc. with multi timeframe chartsMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com
Analyzing BioAtla Inc. with risk reward ratio chartsTrade Performance Summary & Weekly Watchlist of Top Performers - newser.com
What to do if you’re stuck in BioAtla Inc.Sell Signal & Reliable Price Action Trade Plans - newser.com
Chart overlay techniques for tracking BioAtla Inc.July 2025 Sentiment & Technical Confirmation Alerts - newser.com
Is BioAtla Inc. a candidate for recovery playGap Down & AI Powered Trade Plan Recommendations - newser.com
BioAtla, Inc. (NASDAQ:BCAB) Q3 2025 Earnings Call Transcript - Insider Monkey
BioAtla Tightens Belt But Analysts Remain Upbeat - Finimize
BioAtla Reports Q3 2025 Financial Results and Progress - TipRanks
BioAtla Q3 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Bioatla Q3 2025 shows stable EPS, stock dips - Investing.com India
BioAtla (BCAB) Q3 2025 Earnings Call Transcript - AOL.com
BioAtla, Inc. Q3 Earnings Call Highlights Progress and Challenges - TipRanks
Transcript : BioAtla, Inc., Q3 2025 Earnings Call, Nov 13, 2025 - MarketScreener
Earnings call transcript: Bioatla Q3 2025 shows stable EPS, stock dips By Investing.com - Investing.com Canada
BioAtla Inc (BCAB) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Promising Trial ... By GuruFocus - Investing.com Canada
BioAtla Q3 net loss widens to $15.8 mln - MarketScreener
BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress - Investing News Network
BioAtla, Inc. (BCAB) Q3 FY2025 earnings call transcript - Yahoo Finance
Press Release: BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress - 富途牛牛
What analysts say about BioAtla Inc stockMean Reversion Trades & Explosive Profit Trading - earlytimes.in
바이오아틀라 (BCAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):